Oil-in-water type compound fluconazole nano-emulsion and preparation method thereof

Oil-in-water type compound fluconazole nano-emulsion and preparation method thereof

The invention discloses an oil-in-water compound fluconazole nano-emulsion antifungal drug. The nanoemulsion has a droplet diameter between 1 and 100 nm and consists of the following raw materials inpercentage by mass: 25.00%-40.00% of a surfactant, 3.80%-10.00% of a cosurfactant, 3.00%-25.00% of oi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHENG YIN, WEI YUNPENG, OUYANG WUQING, LI XINPING
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHENG YIN
WEI YUNPENG
OUYANG WUQING
LI XINPING
description The invention discloses an oil-in-water compound fluconazole nano-emulsion antifungal drug. The nanoemulsion has a droplet diameter between 1 and 100 nm and consists of the following raw materials inpercentage by mass: 25.00%-40.00% of a surfactant, 3.80%-10.00% of a cosurfactant, 3.00%-25.00% of oil, 0.05%-2.50% of fluconazole, 0.01%-0.70% of magnolol, and the balance of distilled water, and sumof the mass percentages of the above raw materials is 100%. The nano-emulsion preparation is clear and transparent liquid, has good stability, improves solubility of fluconazole, overcomes defect oflow bioavailability of fluconazole in vivo, delays metabolism time of fluconazole in vivo, reduces adjuvant dosage, reduces production cost, and has broad market prospects in the field of medicines. 本发明公开了一种水包油型复方酮康唑纳米乳抗真菌药物，该纳米乳液滴直径大小在1～100nm之间，由下列质量百分比的原料组成：表面活性剂25.00%～40.00%、助表面活性剂3.80%～10.00%、油3.00%～25.00%、酮康唑0.05%～2.50%，厚朴酚0.01%～0.70%，余量为蒸馏水，上述原料的质量百分比之和为100%。该纳米乳制剂是澄清透明液体，稳定性好，提高了酮康唑的溶解度，克服了其在体内生物利用度低的缺点，延缓其在体内的药物代谢时间
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN112089689A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN112089689A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN112089689A3</originalsourceid><addsrcrecordid>eNqNik0KwjAUBrtxIeod4gECVkHapRTFlS50Xx7pVxpI3gv5QfT0KngAV8MwM69uV-u0Zf2gjKjyM0AZ8UEKD2p0xQjTSxwUE4uGLy5ZYUWfGiICRcpf98iTDCpPiJBxWc1GcgmrHxfV-nS8d2eNID1SIANG7rtLXW83Tbtv2sPun-cNnZM5Hg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Oil-in-water type compound fluconazole nano-emulsion and preparation method thereof</title><source>esp@cenet</source><creator>ZHENG YIN ; WEI YUNPENG ; OUYANG WUQING ; LI XINPING</creator><creatorcontrib>ZHENG YIN ; WEI YUNPENG ; OUYANG WUQING ; LI XINPING</creatorcontrib><description>The invention discloses an oil-in-water compound fluconazole nano-emulsion antifungal drug. The nanoemulsion has a droplet diameter between 1 and 100 nm and consists of the following raw materials inpercentage by mass: 25.00%-40.00% of a surfactant, 3.80%-10.00% of a cosurfactant, 3.00%-25.00% of oil, 0.05%-2.50% of fluconazole, 0.01%-0.70% of magnolol, and the balance of distilled water, and sumof the mass percentages of the above raw materials is 100%. The nano-emulsion preparation is clear and transparent liquid, has good stability, improves solubility of fluconazole, overcomes defect oflow bioavailability of fluconazole in vivo, delays metabolism time of fluconazole in vivo, reduces adjuvant dosage, reduces production cost, and has broad market prospects in the field of medicines. 本发明公开了一种水包油型复方酮康唑纳米乳抗真菌药物，该纳米乳液滴直径大小在1～100nm之间，由下列质量百分比的原料组成：表面活性剂25.00%～40.00%、助表面活性剂3.80%～10.00%、油3.00%～25.00%、酮康唑0.05%～2.50%，厚朴酚0.01%～0.70%，余量为蒸馏水，上述原料的质量百分比之和为100%。该纳米乳制剂是澄清透明液体，稳定性好，提高了酮康唑的溶解度，克服了其在体内生物利用度低的缺点，延缓其在体内的药物代谢时间</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201218&amp;DB=EPODOC&amp;CC=CN&amp;NR=112089689A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201218&amp;DB=EPODOC&amp;CC=CN&amp;NR=112089689A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHENG YIN</creatorcontrib><creatorcontrib>WEI YUNPENG</creatorcontrib><creatorcontrib>OUYANG WUQING</creatorcontrib><creatorcontrib>LI XINPING</creatorcontrib><title>Oil-in-water type compound fluconazole nano-emulsion and preparation method thereof</title><description>The invention discloses an oil-in-water compound fluconazole nano-emulsion antifungal drug. The nanoemulsion has a droplet diameter between 1 and 100 nm and consists of the following raw materials inpercentage by mass: 25.00%-40.00% of a surfactant, 3.80%-10.00% of a cosurfactant, 3.00%-25.00% of oil, 0.05%-2.50% of fluconazole, 0.01%-0.70% of magnolol, and the balance of distilled water, and sumof the mass percentages of the above raw materials is 100%. The nano-emulsion preparation is clear and transparent liquid, has good stability, improves solubility of fluconazole, overcomes defect oflow bioavailability of fluconazole in vivo, delays metabolism time of fluconazole in vivo, reduces adjuvant dosage, reduces production cost, and has broad market prospects in the field of medicines. 本发明公开了一种水包油型复方酮康唑纳米乳抗真菌药物，该纳米乳液滴直径大小在1～100nm之间，由下列质量百分比的原料组成：表面活性剂25.00%～40.00%、助表面活性剂3.80%～10.00%、油3.00%～25.00%、酮康唑0.05%～2.50%，厚朴酚0.01%～0.70%，余量为蒸馏水，上述原料的质量百分比之和为100%。该纳米乳制剂是澄清透明液体，稳定性好，提高了酮康唑的溶解度，克服了其在体内生物利用度低的缺点，延缓其在体内的药物代谢时间</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNik0KwjAUBrtxIeod4gECVkHapRTFlS50Xx7pVxpI3gv5QfT0KngAV8MwM69uV-u0Zf2gjKjyM0AZ8UEKD2p0xQjTSxwUE4uGLy5ZYUWfGiICRcpf98iTDCpPiJBxWc1GcgmrHxfV-nS8d2eNID1SIANG7rtLXW83Tbtv2sPun-cNnZM5Hg</recordid><startdate>20201218</startdate><enddate>20201218</enddate><creator>ZHENG YIN</creator><creator>WEI YUNPENG</creator><creator>OUYANG WUQING</creator><creator>LI XINPING</creator><scope>EVB</scope></search><sort><creationdate>20201218</creationdate><title>Oil-in-water type compound fluconazole nano-emulsion and preparation method thereof</title><author>ZHENG YIN ; WEI YUNPENG ; OUYANG WUQING ; LI XINPING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN112089689A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHENG YIN</creatorcontrib><creatorcontrib>WEI YUNPENG</creatorcontrib><creatorcontrib>OUYANG WUQING</creatorcontrib><creatorcontrib>LI XINPING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHENG YIN</au><au>WEI YUNPENG</au><au>OUYANG WUQING</au><au>LI XINPING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Oil-in-water type compound fluconazole nano-emulsion and preparation method thereof</title><date>2020-12-18</date><risdate>2020</risdate><abstract>The invention discloses an oil-in-water compound fluconazole nano-emulsion antifungal drug. The nanoemulsion has a droplet diameter between 1 and 100 nm and consists of the following raw materials inpercentage by mass: 25.00%-40.00% of a surfactant, 3.80%-10.00% of a cosurfactant, 3.00%-25.00% of oil, 0.05%-2.50% of fluconazole, 0.01%-0.70% of magnolol, and the balance of distilled water, and sumof the mass percentages of the above raw materials is 100%. The nano-emulsion preparation is clear and transparent liquid, has good stability, improves solubility of fluconazole, overcomes defect oflow bioavailability of fluconazole in vivo, delays metabolism time of fluconazole in vivo, reduces adjuvant dosage, reduces production cost, and has broad market prospects in the field of medicines. 本发明公开了一种水包油型复方酮康唑纳米乳抗真菌药物，该纳米乳液滴直径大小在1～100nm之间，由下列质量百分比的原料组成：表面活性剂25.00%～40.00%、助表面活性剂3.80%～10.00%、油3.00%～25.00%、酮康唑0.05%～2.50%，厚朴酚0.01%～0.70%，余量为蒸馏水，上述原料的质量百分比之和为100%。该纳米乳制剂是澄清透明液体，稳定性好，提高了酮康唑的溶解度，克服了其在体内生物利用度低的缺点，延缓其在体内的药物代谢时间</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN112089689A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Oil-in-water type compound fluconazole nano-emulsion and preparation method thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T08%3A10%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHENG%20YIN&rft.date=2020-12-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN112089689A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true